Sidelya Ecem YİĞİT, İffet Beril GÖKMEN, Yıldız OKUTURLAR
Turkish Journal of Internal Medicine
2022-Supplement 1
149-151
Pembrolizumab, immune checkpoint inhibitors, lung cancer, hypothyroidism, PD-1, non-small cell lung
88 107